SEC Form 4 · accession 0001209191-18-036065
BIOCEPT INC · BIOC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Bruce Gerhardt
Director
Period of report
Jan 30, 2018
Accepted (ET)
Jun 6, 2018 · 4:33 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001044378
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Jan 30, 2018 | P$0 | 25,000 | — | A | 98,303 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Warrant to Purchase Common StockF1 | $0.50 | Jan 30, 2018 | P | 25,000 | A | Jan 30, 2018 | Jan 30, 2023 | Common Stock | 25,000 | 25,000 | D |
Explanation of responses
- F1The Reporting Person purchased in a public offering 25,000 shares of common stock and warrants to purchase 25,000 shares of common stock at a combined purchase price of $0.45.
- F2Due to a rounding issue, the Reporting Person's prior holdings were overstated by one share.